Dae-Keon Choi

Title: Dae-Keon Choi: Innovator in Bacteriophage Technology

Introduction

Dae-Keon Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of bacteriophage technology, particularly in the development of solutions for combating pathogenic bacteria. His innovative work has the potential to impact various industries, including healthcare and environmental management.

Latest Patents

Dae-Keon Choi holds a patent for a novel bacteriophage and its use in preventing the proliferation of pathogenic bacteria. The patent describes a newly isolated and identified phage that serves as an active ingredient in a composition aimed at inhibiting bacterial growth or killing bacteria. This invention can be utilized in diverse applications, such as preventing or treating bacterial infectious diseases, treating ballast water, and serving as an antibiotic, antiseptic, or feed additive.

Career Highlights

Choi is associated with CTC Bio, Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions that leverage bacteriophage technology to address pressing health and environmental challenges.

Collaborations

Some of Dae-Keon Choi's notable coworkers include Jae-Hoon Kim and Ki-Hong Sung. Their collaborative efforts contribute to the ongoing research and development initiatives at CTC Bio, Inc.

Conclusion

Dae-Keon Choi's contributions to bacteriophage technology exemplify the potential of innovative solutions in addressing bacterial challenges. His work not only enhances our understanding of bacteriophages but also paves the way for practical applications that can benefit society.